Characterization of the tyrosine phosphorylation of calpactin I (annexin II) induced by platelet-derived growth factor
- PMID: 1654883
- PMCID: PMC1151364
- DOI: 10.1042/bj2780447
Characterization of the tyrosine phosphorylation of calpactin I (annexin II) induced by platelet-derived growth factor
Abstract
Stimulation in vivo of Swiss 3T3 fibroblasts with platelet-derived growth factor (PDGF) in the presence of orthovanadate induces the tyrosine phosphorylation of a 39 kDa protein, identified as the phosphorylated slow-migrating form of calpactin I (annexin II) heavy chain, p36. In fact, in PDGF-stimulated cells, anti-(calpactin I) antibodies recognize a doublet of bands, p36 and p39, and the latter disappears upon treatment with phosphatase. In many regards phosphorylation of p39 differs from the rapid and transient phosphorylation of the PDGF receptor and of other substrates: (a) it has slower kinetics but is then stable for longer periods of time; (b) it occurs at 37 degrees C but not at 4 degrees C; and (c) whereas most of the tyrosine-phosphorylated proteins are associated with membrane-enriched preparations, membrane association of p39 only occurs in the presence of Ca2+. Moreover, calpactin I leaks out of permeabilized cells at 0.1 microM free Ca2+, whereas it remains associated with the cells at concentrations of Ca2+ greater than or equal to 1 microM. PDGF does not stimulate phosphoinositide turnover (and thus Ca2+ mobilization) at 4 degrees C; thus it can be suggested that the Ca(2+)-dependent translocation of the protein to membrane/cytoskeletal structures is a necessary condition for its phosphorylation. In addition, calpactin I may not be a direct substrate for the PDGF receptor kinase, but rather the substrate of another tyrosine kinase activated by the receptor.
Similar articles
-
Inhibition of phosphotyrosine phosphatases reveals candidate substrates of the PDGF receptor kinase.Eur J Cell Biol. 1989 Dec;50(2):428-34. Eur J Cell Biol. 1989. PMID: 2560717
-
Epidermal-growth-factor-stimulated phosphorylation of calpactin II in membrane vesicles shed from cultured A-431 cells.Biochem J. 1989 Apr 15;259(2):577-83. doi: 10.1042/bj2590577. Biochem J. 1989. PMID: 2524190 Free PMC article.
-
Antibodies to the N-terminus of calpactin II (p35) affect Ca2+ binding and phosphorylation by the epidermal growth factor receptor in vitro.Biochemistry. 1988 Mar 22;27(6):2069-76. doi: 10.1021/bi00406a038. Biochemistry. 1988. PMID: 2454134
-
Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.Growth Regul. 1993 Sep;3(3):172-9. Growth Regul. 1993. PMID: 8220110 Review.
-
Participation of annexins in protein phosphorylation.Cell Mol Life Sci. 1997 Jun;53(6):522-6. doi: 10.1007/s000180050066. Cell Mol Life Sci. 1997. PMID: 9230930 Free PMC article. Review.
Cited by
-
FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma.Cancer Sci. 2024 Jun;115(6):1896-1909. doi: 10.1111/cas.16140. Epub 2024 Mar 13. Cancer Sci. 2024. PMID: 38480477 Free PMC article.
-
Three are better than one: plasminogen receptors as cancer theranostic targets.Exp Hematol Oncol. 2013 Apr 17;2(1):12. doi: 10.1186/2162-3619-2-12. Exp Hematol Oncol. 2013. PMID: 23594883 Free PMC article.
-
Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/sphingolipid pathway.Redox Biol. 2015;4:169-79. doi: 10.1016/j.redox.2014.12.005. Epub 2014 Dec 16. Redox Biol. 2015. PMID: 25574848 Free PMC article.
-
Annexin A2 and Kidney Diseases.Front Cell Dev Biol. 2022 Sep 2;10:974381. doi: 10.3389/fcell.2022.974381. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36120574 Free PMC article. Review.
-
Annexin II tetramer: structure and function.Mol Cell Biochem. 1995 Aug-Sep;149-150:301-22. doi: 10.1007/BF01076592. Mol Cell Biochem. 1995. PMID: 8569746 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous